The bulk of Prevnar 13 sales come from use in adults, and with Merck & Co in the final stages of regulatory review of its rival vaccine V114 – covering 15 serotypes and filed for adult use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback